Skip to main content
Erschienen in: European Radiology 5/2015

01.05.2015 | Contrast Media

Assessing liver function in patients with HBV-related HCC: a comparison of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging with DWI

verfasst von: Ying Ding, Sheng-Xiang Rao, Caizhong Chen, Renchen Li, Meng-Su Zeng

Erschienen in: European Radiology | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To compare the potential of T1 mapping on gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) and diffusion-weighted imaging (DWI) for assessing liver function in patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC).

Methods

One hundred consecutive patients with known HBV-related HCCs were included. T1 relaxation time and apparent diffusion coefficient (ADC) of the liver were measured, and the reduction rate of T1 relaxation time (∆%) was calculated. T1 relaxation time measurements were compared with ADC values according to the Model for End-Stage Liver Disease (MELD) score.

Results

Hepatobiliary phase (HBP) and ∆% of T1 relaxation time measurements showed significant correlations with MELD score (rho = 0.571, p < 0.0001; rho = −0.573, p < 0.0001, respectively). HBP and ∆% of T1 relaxation time were significantly different between good (MELD ≤8) and poor liver function (MELD ≥9) (p < 0.0001 for both). Areas under the receiver operating characteristic curves (AUCs) of T1 relaxation time for HBP (AUC 0.84) and ∆% (AUC 0.82) were significantly better than for ADC (AUC 0.53; p < 0.0001).

Conclusions

T1 mapping on Gd-EOB-DTPA-enhanced MRI showed promise for evaluating liver function in patients with HBV-related HCC, while DWI was not reliable. HBP T1 relaxation time measurement was equally accurate as ∆% measurement.

Key Points

T 1 mapping on Gd-EOB-DTPA MRI was accurate for assessing liver function.
HBP T 1 relaxation time measurement was as accurate as ∆% T 1
T 1 mapping on Gd-EOB-DTPA MRI was more accurate than DWI-ADC measurement.
Literatur
1.
Zurück zum Zitat Zipprich A, Kuss O, Rogowski S et al (2010) Incorporating indocyanin green clearance into the Model for End Stage Liver Disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis. Gut 59:963–968CrossRefPubMed Zipprich A, Kuss O, Rogowski S et al (2010) Incorporating indocyanin green clearance into the Model for End Stage Liver Disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis. Gut 59:963–968CrossRefPubMed
2.
Zurück zum Zitat Zappa M, Dondero F, Sibert A, Vullierme MP, Belqhiti J, Vilqrain V (2009) Liver regeneration at day 7 after right hepatectomy: global and segmental volumetric analysis by using CT. Radiology 252:426–432PubMed Zappa M, Dondero F, Sibert A, Vullierme MP, Belqhiti J, Vilqrain V (2009) Liver regeneration at day 7 after right hepatectomy: global and segmental volumetric analysis by using CT. Radiology 252:426–432PubMed
3.
Zurück zum Zitat Stauber RE, Wagner D, Stadlbauer V et al (2009) Evaluation of indocyanine green clearance and model for end-stage liver disease for estimation of short-term prognosis in decompensated cirrhosis. Liver Int 29:1516–1520CrossRefPubMed Stauber RE, Wagner D, Stadlbauer V et al (2009) Evaluation of indocyanine green clearance and model for end-stage liver disease for estimation of short-term prognosis in decompensated cirrhosis. Liver Int 29:1516–1520CrossRefPubMed
4.
Zurück zum Zitat Cucchetti A, Ercolani G, Vivarelli M et al (2006) Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl 12:966–971CrossRefPubMed Cucchetti A, Ercolani G, Vivarelli M et al (2006) Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl 12:966–971CrossRefPubMed
5.
Zurück zum Zitat Kamath PS, Kim WR, Advanced Liver Disease Study Group (2007) The model for end-stage liver disease (MELD). Hepatology 45:797–805CrossRefPubMed Kamath PS, Kim WR, Advanced Liver Disease Study Group (2007) The model for end-stage liver disease (MELD). Hepatology 45:797–805CrossRefPubMed
6.
Zurück zum Zitat Tam HH, Collins DJ, Wallace T, Brown G, Riddell A, Koh DM (2012) Segmental liver hyperintensity in malignant biliary obstruction on diffusion weighted MRI: associated MRI findings and relationship with serum alanine aminotransferase levels. Br J Radiol 85:22–28CrossRefPubMedCentralPubMed Tam HH, Collins DJ, Wallace T, Brown G, Riddell A, Koh DM (2012) Segmental liver hyperintensity in malignant biliary obstruction on diffusion weighted MRI: associated MRI findings and relationship with serum alanine aminotransferase levels. Br J Radiol 85:22–28CrossRefPubMedCentralPubMed
7.
Zurück zum Zitat Watanabe H, Kanematsu M, Goshima S et al (2011) Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging—preliminary observations. Radiology 259:142–150CrossRefPubMed Watanabe H, Kanematsu M, Goshima S et al (2011) Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging—preliminary observations. Radiology 259:142–150CrossRefPubMed
8.
Zurück zum Zitat Verloh N, Haimerl M, Zeman F et al (2014) Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla. Eur Radiol 24:1013–1019CrossRefPubMed Verloh N, Haimerl M, Zeman F et al (2014) Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla. Eur Radiol 24:1013–1019CrossRefPubMed
9.
Zurück zum Zitat Utsunomiya T, Shimada M, Hanaoka J et al (2012) Possible utility of MRI using Gd-EOB-DTPA for estimating liver functional reserve. J Gastroenterol 47:470–476CrossRefPubMed Utsunomiya T, Shimada M, Hanaoka J et al (2012) Possible utility of MRI using Gd-EOB-DTPA for estimating liver functional reserve. J Gastroenterol 47:470–476CrossRefPubMed
10.
Zurück zum Zitat Saito K, Ledsam J, Sourbron S et al (2014) Measuring hepatic functional reserve using low temporal resolution Gd-EOB-DTPA dynamic contrast-enhanced MRI: a preliminary study comparing galactosyl human serum albumin scintigraphy with indocyanine green retention. Eur Radiol 24:112–119CrossRefPubMed Saito K, Ledsam J, Sourbron S et al (2014) Measuring hepatic functional reserve using low temporal resolution Gd-EOB-DTPA dynamic contrast-enhanced MRI: a preliminary study comparing galactosyl human serum albumin scintigraphy with indocyanine green retention. Eur Radiol 24:112–119CrossRefPubMed
11.
Zurück zum Zitat Saito S, Moriyama Y, Kobayashi S et al (2012) Assessment of liver function in thioacetamide-induced rat acute liver injury using an empirical mathematical model and dynamic contrast-enhanced MRI with Gd-EOB-DTPA. J Magn Reson Imaging 36:1483–1489CrossRefPubMed Saito S, Moriyama Y, Kobayashi S et al (2012) Assessment of liver function in thioacetamide-induced rat acute liver injury using an empirical mathematical model and dynamic contrast-enhanced MRI with Gd-EOB-DTPA. J Magn Reson Imaging 36:1483–1489CrossRefPubMed
12.
Zurück zum Zitat Kim SU, Kim YC, Choi JS et al (2010) Can preoperative diffusion-weighted MRI predict postoperative hepatic insufficiency after curative resection of HBV-related hepatocellular carcinoma? A pilot study. Magn Reson Imaging 28:802–811CrossRefPubMed Kim SU, Kim YC, Choi JS et al (2010) Can preoperative diffusion-weighted MRI predict postoperative hepatic insufficiency after curative resection of HBV-related hepatocellular carcinoma? A pilot study. Magn Reson Imaging 28:802–811CrossRefPubMed
13.
Zurück zum Zitat Materne R, Smith AM, Peeters F et al (2002) Assessment of hepatic perfusion parameters with dynamic MRI. Magn Reson Med 47:135–142CrossRefPubMed Materne R, Smith AM, Peeters F et al (2002) Assessment of hepatic perfusion parameters with dynamic MRI. Magn Reson Med 47:135–142CrossRefPubMed
14.
Zurück zum Zitat Ding Y, Rao SX, Meng T, Chen C, Li R, Zeng MS (2014) Usefulness of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging in assessment of non-alcoholic fatty liver disease. Eur Radiol 24:959–966CrossRefPubMed Ding Y, Rao SX, Meng T, Chen C, Li R, Zeng MS (2014) Usefulness of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging in assessment of non-alcoholic fatty liver disease. Eur Radiol 24:959–966CrossRefPubMed
15.
Zurück zum Zitat Katsube T, Okada M, Kumano S et al (2011) Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging. Investig Radiol 46:277–283CrossRef Katsube T, Okada M, Kumano S et al (2011) Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging. Investig Radiol 46:277–283CrossRef
16.
Zurück zum Zitat Haimerl M, Verloh N, Zeman F et al (2013) Assessment of clinical signs of liver cirrhosis using T1 mapping on Gd-EOB-DTPA-enhanced 3 T MRI. PLoS One 8:e85658CrossRefPubMedCentralPubMed Haimerl M, Verloh N, Zeman F et al (2013) Assessment of clinical signs of liver cirrhosis using T1 mapping on Gd-EOB-DTPA-enhanced 3 T MRI. PLoS One 8:e85658CrossRefPubMedCentralPubMed
17.
Zurück zum Zitat Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236CrossRefPubMed Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236CrossRefPubMed
18.
Zurück zum Zitat Saito K, Araki Y, Park J et al (2010) Effect of Gd-EOB-DTPA on T2-weighted and diffusion-weighted images for the diagnosis of hepatocellular carcinoma. J Magn Reson Imaging 32:229–234CrossRefPubMed Saito K, Araki Y, Park J et al (2010) Effect of Gd-EOB-DTPA on T2-weighted and diffusion-weighted images for the diagnosis of hepatocellular carcinoma. J Magn Reson Imaging 32:229–234CrossRefPubMed
19.
Zurück zum Zitat Choi JS, Kim MJ, Choi JY et al (2010) Diffusion-weighted MR imaging of liver on 3.0-Tesla system: effect of intravenous administration of gadoxetic acid disodium. Eur Radiol 20:1052–1060CrossRefPubMed Choi JS, Kim MJ, Choi JY et al (2010) Diffusion-weighted MR imaging of liver on 3.0-Tesla system: effect of intravenous administration of gadoxetic acid disodium. Eur Radiol 20:1052–1060CrossRefPubMed
20.
Zurück zum Zitat Muhi A, Ichikawa T, Motosugi U et al (2012) Diffusion- and T2-weighted MR imaging of the liver: effect of intravenous administration of gadoxetic acid disodium. Magn Reson Med Sci 11:185–191CrossRefPubMed Muhi A, Ichikawa T, Motosugi U et al (2012) Diffusion- and T2-weighted MR imaging of the liver: effect of intravenous administration of gadoxetic acid disodium. Magn Reson Med Sci 11:185–191CrossRefPubMed
21.
Zurück zum Zitat Van Beers BE, Pastor CM, Hussain HK (2012) Primovist, Eovist: what to expect? J Hepatol 57:421–429CrossRefPubMed Van Beers BE, Pastor CM, Hussain HK (2012) Primovist, Eovist: what to expect? J Hepatol 57:421–429CrossRefPubMed
22.
Zurück zum Zitat Reimer P, Schneider G, Schima W (2004) Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications. Eur Radiol 14:559–578CrossRefPubMed Reimer P, Schneider G, Schima W (2004) Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications. Eur Radiol 14:559–578CrossRefPubMed
23.
Zurück zum Zitat Lee JM, Zech CJ, Bolondi L et al (2011) Consensus report of the 4th international forum for gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid magnetic resonance imaging. Korean J Radiol 12:403–415CrossRefPubMedCentralPubMed Lee JM, Zech CJ, Bolondi L et al (2011) Consensus report of the 4th international forum for gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid magnetic resonance imaging. Korean J Radiol 12:403–415CrossRefPubMedCentralPubMed
24.
Zurück zum Zitat Kitao A, Zen Y, Matsui O et al (2010) Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging—correlation with molecular transporters and histopathologic features. Radiology 256:817–826CrossRefPubMed Kitao A, Zen Y, Matsui O et al (2010) Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging—correlation with molecular transporters and histopathologic features. Radiology 256:817–826CrossRefPubMed
25.
Zurück zum Zitat Bae KE, Kim SY, Lee SS et al (2012) Assessment of hepatic function with Gd-EOB-DTPA-enhanced hepatic MRI. Dig Dis 30:617–622CrossRefPubMed Bae KE, Kim SY, Lee SS et al (2012) Assessment of hepatic function with Gd-EOB-DTPA-enhanced hepatic MRI. Dig Dis 30:617–622CrossRefPubMed
26.
Zurück zum Zitat Yoshimura N, Saito K, Saguchi T et al (2013) Distinguishing hepatic hemangiomas from metastatic tumors using T1 mapping on gadoxetic-acid-enhanced MRI. Magn Reson Imaging 31:23–27CrossRefPubMed Yoshimura N, Saito K, Saguchi T et al (2013) Distinguishing hepatic hemangiomas from metastatic tumors using T1 mapping on gadoxetic-acid-enhanced MRI. Magn Reson Imaging 31:23–27CrossRefPubMed
27.
Zurück zum Zitat Erturk SM, Alberich-Bayarri A, Herrmann KA, Marti-Bonmati L, Ros PR (2009) Use of 3.0-T MR imaging for evaluation of the abdomen. Radiographics 29:1547–1563CrossRefPubMed Erturk SM, Alberich-Bayarri A, Herrmann KA, Marti-Bonmati L, Ros PR (2009) Use of 3.0-T MR imaging for evaluation of the abdomen. Radiographics 29:1547–1563CrossRefPubMed
28.
Zurück zum Zitat de Bazelaire CM, Duhamel GD, Rofsky NM, Alsop DC (2004) MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology 230:652–659CrossRefPubMed de Bazelaire CM, Duhamel GD, Rofsky NM, Alsop DC (2004) MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology 230:652–659CrossRefPubMed
29.
Zurück zum Zitat Yamada A, Hara T, Li F et al (2011) Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging. Radiology 260:727–733CrossRefPubMed Yamada A, Hara T, Li F et al (2011) Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging. Radiology 260:727–733CrossRefPubMed
30.
Zurück zum Zitat Tamada T, Ito K, Yamamoto A et al (2013) Simple Method for evaluating the degree of liver parenchymal enhancement in the hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging. J Magn Reson Imaging 37:1115–1121CrossRefPubMed Tamada T, Ito K, Yamamoto A et al (2013) Simple Method for evaluating the degree of liver parenchymal enhancement in the hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging. J Magn Reson Imaging 37:1115–1121CrossRefPubMed
Metadaten
Titel
Assessing liver function in patients with HBV-related HCC: a comparison of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging with DWI
verfasst von
Ying Ding
Sheng-Xiang Rao
Caizhong Chen
Renchen Li
Meng-Su Zeng
Publikationsdatum
01.05.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 5/2015
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-014-3542-x

Weitere Artikel der Ausgabe 5/2015

European Radiology 5/2015 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.